Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Malka

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2011
Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumabD Malka, V Boige, N Jacques, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 21, 2015
Prognostic factors for progression-free and overall survival in advanced biliary tract cancerJ Bridgewater, A Lopes, H Wasan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2013
Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trialE Deutsch, C Lemanski, J P Pignon, et al.
British Journal of Cancer|November 8, 2013
Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic studyT Aparicio, M Svrcek, A Zaanan, et al.
Endocrine-Related Cancer|March 15, 2015
Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinomaJ Hadoux, D Malka, D Planchard, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Intra-arterial hepatic chemotherapy in metastatic colorectal cancer: differences between oxaliplatin-naive versus oxaliplatin-pretreated patientsE El Rawadi, B Bonnet, L Pierotti, et al.
Annals of Surgical Oncology|July 20, 2014
FOLFIRINOX for locally advanced pancreatic adenocarcinoma: results of an AGEO multicenter prospective observational cohortL Marthey, A Sa-Cunha, J F Blanc, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 15, 2015
Prognostic score for recurrence after Whipple's pancreaticoduodenectomy for ampullary carcinomas; results of an AGEO retrospective multicenter cohortO Colussi, T Voron, A Pozet, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2017
Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohortT Walter, D Tougeron, E Baudin, et al.
ESMO Open|May 7, 2025
Promoting large multinational academic clinical trials for gastrointestinal cancers in Europe: the ENGIC (European Network for GI Cancers) initiativeJ Taieb, J Seligmann, D Modest, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2011
Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumabD Malka, V Boige, N Jacques, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 21, 2015
Prognostic factors for progression-free and overall survival in advanced biliary tract cancerJ Bridgewater, A Lopes, H Wasan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2013
Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trialE Deutsch, C Lemanski, J P Pignon, et al.
British Journal of Cancer|November 8, 2013
Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic studyT Aparicio, M Svrcek, A Zaanan, et al.
Endocrine-Related Cancer|March 15, 2015
Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinomaJ Hadoux, D Malka, D Planchard, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Intra-arterial hepatic chemotherapy in metastatic colorectal cancer: differences between oxaliplatin-naive versus oxaliplatin-pretreated patientsE El Rawadi, B Bonnet, L Pierotti, et al.
Annals of Surgical Oncology|July 20, 2014
FOLFIRINOX for locally advanced pancreatic adenocarcinoma: results of an AGEO multicenter prospective observational cohortL Marthey, A Sa-Cunha, J F Blanc, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 15, 2015
Prognostic score for recurrence after Whipple's pancreaticoduodenectomy for ampullary carcinomas; results of an AGEO retrospective multicenter cohortO Colussi, T Voron, A Pozet, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2017
Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohortT Walter, D Tougeron, E Baudin, et al.
ESMO Open|May 7, 2025
Promoting large multinational academic clinical trials for gastrointestinal cancers in Europe: the ENGIC (European Network for GI Cancers) initiativeJ Taieb, J Seligmann, D Modest, et al.
Pageof 6